|
AP1S2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.148400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.429800E-02 |
| Normal-vs-Stage2 |
4.557900E-02 |
| Normal-vs-Stage3 |
9.119200E-01 |
| Normal-vs-Stage4 |
4.670100E-02 |
| Stage1-vs-Stage2 |
9.880400E-03 |
| Stage1-vs-Stage3 |
1.266410E-01 |
| Stage1-vs-Stage4 |
6.613200E-01 |
| Stage2-vs-Stage3 |
6.998400E-02 |
| Stage2-vs-Stage4 |
8.516700E-03 |
| Stage3-vs-Stage4 |
2.278200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.656100E-02 |
| Normal-vs-AfricanAmerican |
6.593800E-01 |
| Normal-vs-Asian |
9.621200E-01 |
| Caucasian-vs-AfricanAmerican |
1.375190E-01 |
| Caucasian-vs-Asian |
6.579800E-01 |
| AfricanAmerican-vs-Asian |
8.617400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.842800E-01 |
| Normal-vs-Female |
6.034200E-01 |
| Male-vs-Female |
1.720410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.960600E-01 |
| Normal-vs-Extreme_Weight |
1.523240E-01 |
| Normal-vs-Obese |
9.434800E-01 |
| Normal-vs-Extreme_Obese |
2.352200E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.399400E-01 |
| Normal_Weight-vs-Obese |
9.510400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.224700E-03 |
| Extreme_Weight-vs-Obese |
2.920000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.780500E-03 |
| Obese-vs-Extreme_Obese |
2.401500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.920400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.842600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.995600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.325400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.220600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.449600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.263200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.689000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.551400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.426400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.506100E-02 |
| Normal-VS-Type2 PRCC |
9.920200E-01 |
| Normal-VS-KIRP CIMP |
6.268100E-02 |
| Normal-VS-Unclassified PRCC |
3.025600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.997800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.470100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.426200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.873590E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.873600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.567200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.344600E-01 |
| Normal-vs-N1 |
9.943800E-01 |
| Normal-vs-N2 |
2.688800E-01 |
| N0-vs-N1 |
9.603400E-01 |
| N0-vs-N2 |
5.626000E-01 |
| N1-vs-N2 |
5.521200E-01 |
|
|
